Positive effects of fampridine on cognition, fatigue and depression in patients with multiple sclerosis over 2  years

ConclusionsOur data demonstrate significant positive effects of treatment with PR-fampridine over 2  years on different cognitive domains as well as fatigue and depression in a cohort of PwMS. These findings imply that PR-fampridine should be considered as symptomatic treatment improving aspects of cognition, fatigue and depression in PwMS.
Source: Journal of Neurology - Category: Neurology Source Type: research